SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $65

JMP Securities maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the price target from $75 to $65.

Benzinga · 05/08/2020 12:47

JMP Securities maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the price target from $75 to $65.